Objective: There is increased evidence that oxidative stress is involved in exacerbations of neurodegenerative diseases and spinal muscular atrophies. Methods: We examined changes in morphology and expression of antioxidant proteins and peroxiredoxins in motor neurons of lumbar spinal cord, dorsal root ganglion sensory neurons, macroglial cells and quadriceps muscles of newborn heterozygous Loa/+ mice ("legs at odd angles"), a mouse model for early onset of the spinal muscular atrophy with lower extremity predominance (SMA-LED). Results: Our data indicate that newborn Loa-mice develop: neuroinflammation of the sensory and motor neurons; muscular inflammation with atrophic and denervated myofibers; increased expression of neuronal mitochondrial peroxiredoxins (Prxs) 3, 5 and cytoplasmic Prx 6 in motor and sensory neurons, myofibers, fibroblasts of perimysium and chondrocytes of cartilage; and decreased expression of Prx 6 by glial cells and in extracellular space surrounding motor neurons.
INTRODUCTION

Spinal muscular atrophy-lower extremity, dominant (SMA-LED)
Mutations in the tail domain of the heavy chain of cytoplasmic dynein DYNC1H1 gene are the cause of spinal muscular atrophy with lower extremity predominance (SMA-LED) [1] . SMA-LED is a rare, degenerative, inherited disease [1, 2] . Typical clinical features in patients with the SMA-LED include: late infantile motor development, unstable gait, proximal lower limb-dominant muscle weakness or atrophy and difficulty squatting [1, 3, 4] .
Muscle computer tomography demonstrated severe atrophy and lipid degeneration, predominantly in the bilateral quadriceps femoris [3] . A muscle biopsy demonstrated chronic denervation, accumulation of inflammatory cells surrounding perimysial blood vessels, a massive increase in the amount of fibrous tissue and enlarged type 1 fibers [3, 4] . Additionally, a magnetic resonance imaging of the thigh muscles demonstrated diffuse atrophy and fat replacement in young patients [5] . All these findings indicate that hallmarks of the SMA-LED are early childhood onset of degeneration of spinal cord motor neurons, proximal leg weakness with muscle atrophy and non-lengthdependent motor neuron disease without sensory involvement [1, 3, 4] .
Loa/+ mice and evidence of oxidative stress
The Loa/+ mouse ("legs at odd angles") is a wellestablished model of SMA-LED. These mice have a dynein mutation of the DYNC1H1 gene and show disruption in transport of neuronal cargoes. Loa/+ mice may represent an ideal system to model the pathophysiological effects of the SMA-LED human mutation [6] . The heterozygous Loa/+ mice develop pathological features similar to the SMA-LED early onset: abnormal motor neuron innervation, decreased number of spinal cord ventral horn motor neurons, motor neuron degeneration, impaired coordination, abnormal grip strength, muscle spasms, accumulation of fat in tissues and abnormal mitochondrial morphology and function [7] [8] [9] [10] . Typical pathological findings in heterozygous Loa/+ mice include earlyonset degeneration of spinal motor neurons and proprioceptive sensory neuropathy, muscle spindle deficiency, neuromuscular junction defects, neuronal migration, alteration of axonal transport of cargoes, abnormalities due to alteration of the morphology of motor neurons and vacuolar mitochondria [8, [11] [12] [13] . It was proposed that such changes in morphology of mitochondria correlate with oxidative stress in other neurodegenerative diseases with imbalance between oxidant and antioxidant proteins [14] [15] [16] .
Mitochondrial dysfunction and oxidative stress are one of the main mechanisms associated with the pathogenesis of other neurodegenerative diseases, pathological conditions and aging [15, [17] [18] [19] [20] . Recent studies show that Prxs 3 and 5 are major mitochondrial antioxidant proteins in the brain [21] [22] [23] . Prx 6 is an antioxidant protein widely expressed in all tissues, with unique ability to inactivate reactive oxygen species (ROS) and lipid peroxides [24, 25] . Under physiological conditions astrocytes express and secrete Prx 6 in the extracellular space in the anterior horn of the spinal cord [26] or brain [27] to protect neuronal DNA, proteins and lipids from oxidative damage and prevent neuronal loss and both astrocytes and oligodendrocytes in adult mouse brain [28] . Altered expression of Prx 6 in the central nervous system (CNS) was shown in neurodegenerative [29] and neurological diseases [30] , experimental cerebral ischemic damage [31] and experimental spinal cord damage [32] . Moreover, increased oxidative stress was described in white adipose tissue of Loa/+ mice [10] .
Because of increasing evidence that oxidative stress can be involved in pathology of SMA-LED, we conducted an analysis of the expression of antioxidant proteins, Prxs 3, 5 and 6, in lumbar spinal neurons and quadriceps muscle of newborn Loa/+ mice and determined whether morphological and ultrastructural changes occur.
MATERIAL AND METHODS
Mice
Data were derived from six heterozygous newborn Loa/+ pups and two newborn wild type littermates (congenic on a C57BL/6J background). The animal breeding and studies reported in this paper were carried out under license from the UK Home Office (Animals Scientific Procedures Act 1986) and local ethical review panel under the guidance issued by the Medical Research Council and for the tissue processing and analysis at the University of Nevada, Reno, from UNR's institutional animal care and use committee.
Genotyping
Forward (TGCTGTGTGCTCTCCTGTTT) and reverse (TTTTACAAGCTTGGCTTTGC) primers were used to amplify a 696 bp product encompassing the Loa mutation site. The polymerase chain reaction (PCR) conditions were 35 cycles at 95°C for 30 sec, 62°C for 30 sec and 72°C for 1 min. The Loa mutation introduces an additional RSA1 restriction site within the 696 bp product and thus PCR products were digested with RSA1 (New England Biolabs) for 2 h at 37°C. Products were run on a 2% agarose gel to determine the genotypes.
Histology
Newborn mice were anesthetized and fixed with 4% paraformaldehyde for storage. Fixed mice were dissected (quadriceps muscles from both legs and whole segment of lumbar spinal cord from all eight mice), dehydrated in graded ethanols, cleared in xylene, and embedded in paraffin (Paraplast Plus). Paraffin blocks were cut and 5 µm thick sections were collected on silane-coated slides (Surgipath Snowcoat X-tra) and immunostained and counterstained with 0.01% thionin to perform morphological and quantitative immunohistochemical analysis.
Morphometric analysis
For quantification of connective tissue in muscles, we randomly sampled five counting boxes from ten sections per muscle. We measure the fractional area of connective tissue by using point counting the size of one counting box = 0.16 mm 2 per box was 100%. For quantification of number of myofibers with central location of nucleus or atrophic myofibers, we counted the number of these myofibers in one counting box = 0.16 mm 2 . Five counting boxes per section were randomly selected from ten sections per muscle.
Immunohistochemistry (IHC)
Mouse spinal cord, thigh muscle and muscular tender tissues were fixed with 4% paraformaldehyde. Fivemicrometer paraffin sections were collected, deparaffinized in xylene and hydrated in ethanol series. Sections were incubated with 3% hydrogen peroxide for 30 min to block endogenous peroxidase activity, and then nonspecific binding sites were blocked with 2.5% normal horse serum in phosphate buffer for 20 min. Sections were washed in phosphate buffer (pH 7.5) and incubated with rabbit primary antibody against Prx 6 (Abcam, ab73350) at a concentration of 1 μg/ml, or rabbit primary antibody against Prx 3 (Abcam, ab73349) at a concentration of 5 μg/ml, or rabbit primary antibody against Prx 5 (Abcam, ab140926) diluted 1/200. Then, sections were incubated for 30 min with ImmPRESS™ reagent (antirabbit secondary antibody; Vector Laboratories, UK: #MP-7401). The complex was visualized with ImmPACT™ DAB (peroxidase substrate solution; Vector Laboratories, UK: #SK-4105). Then, sections were counterstained with 0.01% thionin, cleared (ethanol, xylene) and mounted with a neutral plastic resin dissolved in xylene and containing di-n-butyl phthalate as a plasticiser (DBP; in xylene: DPX). We used negative control to test for the specificity of the antibodies by checking staining after omitting the primary antibody. After IHC reaction, these sections were digitized and analyzed at the light microscopy level with NIS-Elements software (Nikon) for quantification to compare the levels of expression of Prxs 3, 5 and 6 by measuring values of pixel intensity.
Quantitative immunohistochemistry (Q-IHC)
A Q-IHC analysis was employed to determine levels of expression of Prxs in the neurons of lumbar spinal cord, thigh muscle and muscular tender tissues. RGB images acquired by NIS-Elements software were analyzed before saving and converting to JPG format. After IHC, sections contain different levels of chromogen, from light brown to brown in wild type (WT) mice sections, and from light brown to almost black in Loa/+ mice. The chromogen quantity was determined by reciprocal pixel intensity in percentage where "white area" (area without tissue) have maximal pixel intensity (100%). The detailed protocol for calculation of the reciprocal pixel intensity is available online [33] . To avoid bias, we used manual "point analysis" of selected cells in each image. This is different from the Q-IHC method which measured "area analysis" by normalizing energy of the area per pixel [34] . We measured pixel intensity in three areas: (1) area of interest; (2) "white area", area without tissue for each slide; (3) negative control sections for each sample. To minimize background we used counterstaining with thionin, which stained tissue with light blue color. Previously, not significant differences were detected in chromogen quantity with and without counterstaining [34] . To calculate the chromogen quantity, we subtracted the combine pixel intensity (%) of area of interest of experimental image and homologous region of negative control from pixel intensity (%) of "white area" of each section. Pixel intensity from twenty cells was collected from each section. Data from a minimum of 200 cells (such as neurons, glial cells, fibroblast, myofibers and chondrocytes) was compared for each condition (WT and Loa/+ mice). To prevent observer bias, sections were coded to ensure that the observer was blind to their condition. To determine P values for statistical significance an unpaired two-tailed Student's t-test was used, and P values were calculated using SigmaStat software (Jandel Scientific). The significance level was set at P < 0.05.
Electron microscopy
Newborn mice were anesthetized and fixed with 4% paraformaldehyde for storage. Fixed mice, in 2% paraformaldehyde and 3% glutaraldehyde (GA) in 0.1 M sodium cacodylate buffer (pH 7.3) were dissected (quadriceps muscles and lumbar spinal cord), postfixed in 1% osmium tetroxide, dehydrated in graded ethanols, treated with propylene oxide and embedded in Spurr resin. Resin blocks were cut and 1 µm thick sections were collected on glass slides and stained with 1% toluidine blue for morphological analysis by using a Nikon light microscope equipped with NIS-Elements software for quantitative analysis and for orientation and selection of areas for further ultrastructural examination. Ultrathin sections (80 nm) were stained with 2.5% aqueous lead citrate and uranyl acetate. Sections were examined and digitized in a Philips CM10 transmission electron microscope equipped with a Gatan 792 BioScan digital imaging system. We determined the fractional area of cytoplasm with polyribosomes as was described previously [15] . For quantification of the number of damaged mitochondria in cell bodies of motor neurons, we counted the number of these mitochondria in one counting box = 2.25 µm 2 . Twenty counting boxes per one section were randomly selected from ten sections per muscle. The total area of cell bodies of motor neurons sampled in WT and Loa/+ mice with 20 neurons was 450 µm 2 .
RESULTS
To identify early morphological changes of pathological conditions we compared newborn Loa/+ and WT mice at both light and electron microscopic levels.
Morphometry at the light-microscopic level Lumbar sensory and motor neurons of the spinal cord
Alpha motor neurons were identified by their size (more than 13 µm in diameter, [10] ) and specific location in the ventral horn (Figs.1ABDEF). Neuroinflammation in newborn Loa/+ mice was determined by two morphological features: (1) significantly increased size of sensory neurons in Loa/+ mice in comparison to WT mice (12.2 ± 2.8 µm; 5.9 ± 0.5 µm), and (2) accumulation of activated microglia around motor neurons in Loa/+ mice (Fig.1B) . The status of "activated" microglia was determined by ultrastructural features (see below in 'electron microscopy' subsection).
Quadriceps muscle
To compare published data of human quadriceps muscle pathology in SMA-LED with data from Loa/+ mice we performed morphological analysis of the same muscle in Loa/+ mice. Our data indicate early pathological changes in the muscles of newborn Loa/+ mice. The quadriceps muscle displays several pathological features: increased amount of connective tissue between myofibers (5 ± 1% in WT, 16 ± 4% in Loa/+ mice), which is typical for muscular inflammation, fibrosis and dystrophy; increased number of atrophic myofibers (1 ± 0.5% in WT, 4.5 ± 2.5% in Loa/+ mice), which is an early sign of muscle dystrophy; and also increased number of myofibers with central position of the nucleus (2.5 ± 1.3% in WT, 12.1 ± 5% in Loa/+ mice) which is typical for both fibrosis and dystrophy (data are mean ± SEM; Fig.2 ) [35] . 
Electron microscopy Sensory and motor neurons
Ultrastructural analysis of sensory and motor neurons showed early alteration in morphology of newborn Loa/+ mice. The pathological changes were similar for both types of neurons, but in the motor neuron they were severe. Ultrastructural images of lumbar sensory and motor neurons show signs of neuroinflammation: increased number of damaged mitochondria (9 ± 2.4% in WT, 20 ± 6.1% in Loa/+ mice); decreased number of polyribosomes (55 ± 5% area of all cytoplasm in WT, 35 ± 2% in Loa/+ mice); elongation of smooth endoplasmic reticulum and a relocation of heterochromatin accumulations from center to neuronal nuclear membranes and appearance of nuclear invaginations and inclusions in Loa/+ neurons (Fig.3) .
Activated microglia
Another distinguished feature of spinal motor neurons in Loa/+ mice was the accumulation of microglial cells. Detailed ultrastructural analysis of these microglial cells shows increased numbers of secretory granules and increased size of cell body, which is typical for activated microglial cells during acute neuroinflammation [36] . Increased number and accumulation of activated microglia (macrophages in CNS) near motor neurons indicate that these neurons are experiencing severe neuroinflammation. Ultrastructure features of activated microglia (Fig.1C) and other alteration at morphology of sensory and motor neurons (Fig.3) are similar to what was described after injection of brain lipopolysaccharide (LPS), a component of outer membrane of Gramm-negative bacteria which induce inflammation and increase oxidative stress [36] . 
Quantitative immunohistochemistry
Increased numbers of damaged mitochondria in motor and sensory neurons can be a result of increased oxidative stress due to imbalance in generation of ROS and expression of antioxidant proteins, peroxiredoxins.
To compare the levels of expression of mitochondrial antioxidant proteins, Prxs 3 and 5, cytoplasmic Prx 6 and secretory Prx 6, we performed a Q-IHC analysis. The comparison of pixel intensity after IHC identifies several significant changes in expression of these antioxidant proteins in newborn Loa/+ mice. Fig.5F ). Expression of cytoplasmic Prx 6 was significantly decreased in glia surrounding motor neurons (37.92 ± 3.62% vs 59.63 ± 4.63%, P = 0.001, (Figs.4CD, Fig.5B ). Expression of Prx 6 was not significantly different in sensory neurons (P = 0.209, (Fig.5E) . The secretory Prx 6 in the extracellular space between motor neurons was decreased in Loa/+ mice (10.51 ± 1.16% vs 24.95 ± 2.05%, P = 0.001, Figs.4CD, Fig.5C ).
Surprisingly, both macroglial cells astrocytes and oligodendrocytes, surrounding motor neurons expressed Prx 6 in WT mice. We determined the expression of Prx 6 in macroglia in white matter of lumbar spinal cord of WT mice. Our data show that oligodendrocytes expressed more cytoplasmic Prx 6 than astrocytes (83.4 ± 1.03% vs 71.67 ± 2.4%). Using morphological criteria at the light microscopic level to identify astrocytes and oligodendrocytes we analyzed expression of Prx 6 separately in macroglial cells to identify which macroglial cells participate in expression of secretory Prx 6 in extracellular space between motor neurons. Both macroglial cells types in Loa/+ mice showed significantly decreased expression of Prx 6; however, there was a dramatic decrease in oligodendrocytes (P = 0.001). Further experiments are required to clarify the role of macroglial cells on reduction of secretory Prx 6 in extracellular space between motor neurons. Quadriceps muscle: expression of Prx 6 in newborn Loa/+ mice was significantly increased in the sarcoplasm of myofibers (55.2 ± 4.04% vs 38.3 ± 3.23%, P = 0.008; Fig.5G, Figs.6AD) , in the fibroblasts of perimysium (44.08 ± 2.21% vs 27.43 ± 3.64%. P = 0.001; Fig.5H, Figs.6CF) , and in the chondrocytes of tendon (45.88 ± 4.56% vs 24.5 ± 2.01%, P = 0.002; Fig5D, Figs.6BE) . Expression of Prx 6 was significantly decreased in the intercellular cartilage matrix (0.5 ± 0.1% vs 7 ± 1.16%, P = 0.004; Figs.6BE). Expression of Prx 6 was not significantly changed in the perimysium between fibroblasts (P = 0.314) and in satellite cells near myofibers (P = 0.529). Taken together, these data indicate that motor neurons, dorsal root ganglion sensory neurons, glial cells surrounding them at the lumbar spinal cord level, and the quadriceps muscle of newborn Loa/+ mice experience oxidative stress, which may participate in morphological pathology and indicates an early onset of the disease.
Immunohistochemical analysis of spinal cord motor neurons (A-D) and dorsal root ganglion sensory neurons (E-H). (A) Expression of Prx 5 in motor neurons (arrowhead) and glial cells
DISCUSSION
This study is the first to examine early pathological changes caused by the DYNC1H mutation on spinal lumbar motor neurons and sensory neurons of the dorsal root ganglion in newborn heterozygous Loa/+ mice at the ultrastructural level and to provide quantification of the expression of antioxidant proteins, such as Prxs 3, 5 and 6. We show that spinal lumbar sensory and motor neurons experience oxidative stress and display neuroinflammatory ultrastructural changes at an early postnatal stage. Here, we propose that chronic oxidative stress and inflammation may be involved in neurodegeneration of spinal lumbar neurons and lead to pathological changes in the quadriceps muscle and muscular tendon and this may contribute to the exacerbation of SMA-LED with age in human patients.
Accumulation of activated microglial cells around spinal motor neurons in ventral spinal cord indicates on acute neuroinflammation and acute stage of oxidative stress (Fig.7) . Increased sizes of sensory neurons of the dorsal root ganglion indicate a mild neuroinflammation and mild oxidative stress (Fig.7) . Other features of increased oxidative stress in motor and sensory neurons are an increased number of damaged mitochondria together with increased expression mitochondrial Prxs 3 and 5. Reduction of polyribosomes can lead to decrease of protein synthesis in spinal sensory and motor neurons in newborn Loa/+ mice. This reduction may be caused by alteration in attachment of ribosomes to cytoplasmic dynein and may also be the result of increased oxidative damage of motor proteins [36] and in this case is progressive with age, which is true for both human SMA-LED and mouse DYNC1H Loa mutations. Altered structure of endoplasmic reticulum is typical for a range of neurological disorders, including amyotrophic lateral sclerosis (ALS) [37, 38] . Presumptive changes of expression of antioxidants in physiological and pathological conditions related to oxidative stress. At normal physiological conditions an oxidative stress is absent. Medium expression of antioxidants neutralize an oxidant's (e.g. ROS) production, as part of signaling pathways. During early pathological stages (presymptomatic stage) an up-regulated expression of antioxidants tries to balance mild level of an oxidant's production. During a symptomatic stage of pathologies related to oxidative stress natural antioxidant defense failed to protect tissues from oxidative damage and cause irreversible changes. This leads to chronic stage of pathologies (e.g. late stages of cystic fibrosis, cancer, aging) with depression of expression of antioxidants and elevated levels of oxidants.
Activated microglia cells are an additional source of ROS which produces oxidants through activation of NADPH-oxidase [39] [40] [41] . Microglia toxicity or microglia-mediated neuroinflammation are important components which increase oxidative stress and contribute to neurodegenerative and pathological conditions in the CNS [40] [41] [42] [43] . Though activated microglia generate ROS and increase oxidative stress, it was shown that they also produce antioxidant proteins, such as Prxs 1, 2 and 5 to reduce oxidative stress [39, 44, 45] . This antagonistic feature of microglia was investigated in separate studies. In the text below and Fig.7 we discuss this opposite ability of glia to generate ROS and Prxs. Immunohistochemical findings of this study indicate that not only astrocytes but also oligodendrocytes can express Prx 6 in lumbar spinal cord in both WT mice and Loa/+ mice. This finding in spinal cord confirms previously reported expression of Prx 6 in adult mouse brain [28] . Our data indicate that expression of Prx 6 in developmental spinal cord of newborn pups differ from the expression in adult spinal cord of mice [26, 32] . The dynein mutation of Loa/+ mice decreased the expression of Prx 6 in both macroglial cell types, especially in oligodendrocytes, located around motor neurons. The decreased expression of Prx 6 by macroglia may contribute to decreased levels of this protein in the extracellular space between the motor neurons and creation of toxic environment. Decreased expression of Prx 6 in oligodendrocytes, which form myelin sheath of axons in the CNS, may also contribute to change in its redox status and lead to oxidative damage of axons and neuromuscular junctions which are typical for Loa/+ mice. Current findings show altered morphology and expression of the antioxidant proteins of the quadriceps muscle in early stage of the pathology. On the one hand, morphological changes of the quadriceps muscle point to muscle inflammation and early development of atrophy and denervation of the myofibers. On the other hand, increased expression Prx 6 indicates increased oxidative stress. The expression of Prx 6 is altered under several pathological conditions [26, 30, [46] [47] [48] . In the neurodegeneration of ALS, the expression of Prx 6 was significantly up-regulated in astrocytes of the spinal cord in 6-to 8-week-old SOD1 transgenic mice [46] . The authors suggest that up-regulation of Prx 6 is a defensive antioxidant reaction. In addition, an in vitro study showed that astrocytes expressing mutated SOD1 kill spinal primary and embryonic mouse stem cellderived motor neurons [49] . In this case it was proposed that astrocytes may play a role in the specific degeneration of spinal motor neurons in ALS, and identification of the astrocyte-derived soluble factor(s) may have far-reaching implications for ALS from both pathogenic and therapeutic standpoints [49] . We speculate that astrocytes of SOD1 transgenic mice produce a high amount of ROS which induce lipid peroxidation; this leads to chronic oxidative stress and causes death of motor neurons. The defensive antioxidant reaction, up-regulated expression of Prx 6, is not sufficient to prevent this process. Previously, it was proposed that expression of Prx 6 increased in response to mild oxidative stress and decreased in response to severe oxidative stress [50] . A similar mechanism was proposed for other antioxidant proteins in pathological conditions [51] [52] [53] . Our data indicate that the lumbar spinal sensory neurons, the quadriceps muscle and the muscular tendon encounter mild oxidative stress at this early stage of the pathology, while the motor neurons of the ventral horn are exposed to acute oxidative stress in the lumbar spinal cord. Similar to astrocytes of SOD1 transgenic mice, macro-and microglia of Loa/+ mice first generate ROS and reactive nitrogen species (RNS) and increase oxidative stress, and later they express antioxidant proteins, including Prxs, to repair damage caused by oxidants (Fig.7) . Although Loa/+ mice and SOD1 transgenic mice are mouse models for different diseases, our data indicate that these mutations have some similar pathological features, such as altered expression of secretory Prx 6 by macroglial cells located around degenerating motor neurons which point to increased oxidative stress. Ability of glia to express other types of Prxs, such as Prx 1, 2, 4 and 5, was shown in other pathologies [39, 44, 45, [54] [55] [56] . These changes in expression of Prxs point to its diversity and distinct functional roles in different pathologies, including neurological and neurodegenerative diseases [30] . Fig.7 presents a model of oxidative stress, which explains altered expression of Prxs in relationship with level of oxidative stress in our study. Under physiological conditions, an intermediate level of antioxidants and oxidants is generated; both of them are important for cellular signaling. Under pathological conditions (for example early stages of SMA-LED during embryogenesis and early childhood) there is an increase in the generation of oxidants followed by an increased expression of antioxidants. This condition is the first stage of oxidative stress (mild oxidative stress) and this condition is reversible if sufficient amounts of the antioxidant proteins are present. If not, it leads to development of acute oxidative stress with a significant imbalance: increased amount of oxidants and decreased amount of antioxidants and in this stage of oxidative stress there typically is irreversible damage of cellular organelles. When these conditions exist for a longer time, the severe imbalance persists and causes chronic oxidative stress, which leads to cell death.
How do the data of our current research fit with the pathological mechanism of Loa/+ mutation? Fig.8 shows the pathological mechanism of Loa/+ mutation and interaction between motor neurons and glia. Motor neurons of Loa/+ mice are more susceptible to oxidative stress caused by the dynein mutation because it slows down the retrograde traffic of mitochondria to cell body for recycling and thereby causes damage of mitochondria and increased "leakage" of superoxide anion and ROS into the cytoplasm [57] . Then, in the cytoplasm superoxide anions and ROS start free radical chain reactions, which damage cellular organelles, RNA, DNA, proteins, lipids and membranes.
Comparison of the two mutant mice, namely SOD1
G93A
and DYNC1H Loa + SOD1 G93A (double mutation), point to the importance of retrograde transport of mitochondria. SOD1 G93A mice have mitochondrial SOD1 mutation, axonal transport defects and short lifespan [6, 58] . Mice with DYNC1H Loa and SOD1
double mutation have restoration of the retrograde transport of cellular organelles, including mitochondria, to neuronal cell body where autophagic recycling of mitochondria occurs [59] and consequently leads to significant reduction of SOD1 protein which is located in the mitochondrial matrix [9] that determine amelioration of pathology of deadly SOD1 G93A mutation with significant increase in life extension [6] .
A high level of energy metabolism, increased number of mitochondria, lack of catalase (CAT), lower rates of regeneration [57] and large size of motor neurons aggravate oxidative stress in the motor neurons. During normal aging, human tissues show a decrease in expression and activity (due to overoxidation) of antioxidant proteins, particularly Prxs, but not SOD and CAT [60] [61] [62] [63] , and increase generation of ROS [64] [65] [66] ; neurons became less protective from oxidative stress which leads to typical increase of neurodegenerative diseases with age.
A recent study shows that a natural activator of the antioxidant enzyme Prx 6 is glutathione S-transferase (GST) pi [25] . At a pre-symptomatic age (70 days), expression of this protein was unchanged, but it was decreased at a symptomatic age (140 days) in SOD1 mice, but not in Cra1/SOD1 mice. Expression of this protein was stable in the spinal cord of Cra1 mutant mice when compared with WT mice [67] ; the authors conclude that the DYNC1H1 mutation reduces the toxic effects caused by the SOD1 mutation in Cra1/SOD1 mice. Because of the similarity of Loa and Cra1 mutations, it is possible that Loa/+ mice also have a normal level of expression of GST pi. A deficit in Prx 6, but not of its activator may regulate neurodegeneration in Loa/+ mice. The data presented in the current study suggest that decrease in secretion of Prx 6 by macroglia leads to a decrease in the amount of this protein in the extracellular space surrounding motor neurons at early stages of the pathology and leads to development of toxic conditions such as chronic oxidative stress, and this may cause degeneration of lumbar motor neurons. Thus, a deficit of Prx 6 may be detrimental to the survival of motor neurons and cause progression of the pathology, and may be a key target for future therapeutic strategies to address symptoms of the DYNC1H1 mutation [68] . A similar mechanism was proposed for degeneration of motor neurons in ALS [69] . Pathological findings from muscles of human patients with the SMA-LED also indicate a possible deficit of Prx 6, where a massive increase in the amount of fibrous tissue, lipid degeneration and replacement of muscle by fat tissue was described [1, [3] [4] [5] . Since Prx 6 can prevent accumulation of fibroblasts in fibrous tissue [70] , and can decrease lipid degeneration by turnover of lipid peroxidation [25] , we propose that exogenous administration of Prx 6 at early stages of SMA-LED may reduce pathology in the muscle and decrease degeneration of motor neurons. Because it was suggested that early diagnosis and proactive care extend significantly the lifespan of SMA patients, and treatment at the neonatal stage is an option [71] , we predict that preventive therapeutic interventions in fetuses, infants and children may be the most effective. The data on newborn Loa/+ mice suggest a protective function of Prx 6 in motor neuron disease models. The significant decrease in glial and extracellular Prx 6 expression in early stages of the pathology is consistent with the hypothesis that chronic oxidative stress may lead to neurodegeneration of motor neurons. Accordingly, we predict that exogenous administration of this protein will ameliorate oxidative stress and pathology in an animal model of SMA-LED and may be considered as new approach in future pediatric therapeutic interventions to prevent progression of the disease.
